InvestorsObserver
×
News Home

Is IM Cannabis Corp (IMCC) a Stock to Watch After Losing 0.00% This Week?

Tuesday, August 16, 2022 11:30 AM | InvestorsObserver Analysts

Mentioned in this article

Is IM Cannabis Corp (IMCC) a Stock to Watch After Losing 0.00% This Week?

Overall market sentiment has been high on IM Cannabis Corp (IMCC) stock lately. IMCC receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
IM Cannabis Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on IMCC!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With IMCC Stock Today?

IM Cannabis Corp (IMCC) stock is trading at $0.62 as of 11:29 AM on Tuesday, Aug 16, a drop of -$0.03, or -4.3% from the previous closing price of $0.65. The stock has traded between $0.60 and $0.71 so far today. Volume today is below average. So far 217,063 shares have traded compared to average volume of 348,855 shares.

More About IM Cannabis Corp

IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Click Here to get the full Stock Report for IM Cannabis Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App